Clinical trials
Active, not recruiting Pancreatic Neoplasms trials in the United States
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
152 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 1 |
| 2009 | 1 |
| 2010 | 2 |
| 2012 | 2 |
| 2014 | 1 |
| 2015 | 7 |
| 2016 | 8 |
| 2017 | 6 |
| 2018 | 7 |
| 2019 | 16 |
| 2020 | 21 |
| 2021 | 23 |
| 2022 | 17 |
| 2023 | 21 |
| 2024 | 13 |
| 2025 | 6 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Active, not recruiting | 152 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| M.D. Anderson Cancer Center | 13 |
| Memorial Sloan Kettering Cancer Center | 12 |
| National Cancer Institute (NCI) | 12 |
| H. Lee Moffitt Cancer Center and Research Institute | 6 |
| Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 6 |
| Massachusetts General Hospital | 5 |
| City of Hope Medical Center | 4 |
| Eli Lilly and Company | 3 |
| Jonsson Comprehensive Cancer Center | 3 |
| Mayo Clinic | 3 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Pancreatic Neoplasms | 152 |
| Colorectal Neoplasms | 28 |
| Ovarian Neoplasms | 24 |
| Carcinoma, Non-Small-Cell Lung | 22 |
| Breast Neoplasms | 21 |
| Stomach Neoplasms | 21 |
| Colonic Neoplasms | 17 |
| Lung Neoplasms | 15 |
| Esophageal Neoplasms | 14 |
| Neoplasm Metastasis | 14 |
Trials
Showing 1 to 25 of 152. Each trial links to its page on Pharma Observatory.
52 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.